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INTRODUCTION
Efficient T-cell adaptive immune responses take place in secondary lymphoid organs such as lymph nodes (LN). Thus, circulating T lymphocytes have to leave the blood stream to home in LN through high endothelial venules (HEVs) and perform their surveillance task. This motile behavior necessitates a tight control of expression of some cell surface proteins such as the adhesive molecules CD62L and LFA-1, and the CCR7 chemokine receptor (1) . In addition, many signaling pathways responsible for profound alterations in T lymphocyte morphology are activated during this migratory process and during motility inside LN (2) .
Using a large scale study of the genes that are specifically controlled by FOXO1 in human T cells, we have previously shown that FOXO1 regulates a much larger set of genes than previously expected. In addition to controlling a specific category of genes involved in T lymphocyte quiescence and survival, FOXO1 also controls expression of the CD62L and CCR7 homing receptors (3). These results have been largely confirmed in murine systems (reviewed in 4). However, no putative transcriptional targets of FOXO1 involved in the control of signals transduced downstream these homing receptors have been identified so far.
Here, we describe the function of a new gene controlled by FOXO1 called fam65b that fulfils such a function. In resting T cells, we report that Fam65b negatively regulates adhesion, polarisation and migration. Mechanistically, we show that Fam65b represses these responses by inhibiting RhoA activity, a GTPase particularly important for cell migration (5) .
This shows the existence of a novel and unsuspected link between FOXO1 and RhoA pathways. Taken together, our results demonstrate that Fam65b is a target gene of FOXO1
that regulates the triggering threshold of RhoA-dependent chemokine responses.
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Materials and Methods
In silico analysis
The following publicly accessed databases were used: BLAST, UniGene, GeneCards, 
qRT-PCR
Total RNA was prepared using RNeasy mini kit (Qiagen). cDNA was produced with the 
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Luciferase assays
The FOXO1 enhancer in the iso1 (130 650-131 815) and iso2 promoter region (164 220-165 360) was amplified from human genomic DNA using the following set of primers: iso1- cell lysis buffer (500 µl) and luciferase activity was assayed using the Dual-Luciferase
Reporter assay system (Promega) as per the manufacturer's instructions.
Constructs
The pEGFP-C3-RhoAN19 constructs was provided by M.R. Philips (New York University School of Medicine, USA). The FOXO1(3A)-GFP and FOXO1(3A,H215R)-GFP plasmids were previously described (3, 6) . Lentiviral vectors TRIPiziE encoding GFP or FOXO1(3A)-GFP were described (3). Fam65b(2) was PCR-amplified using a V5-tagged Fam65b vector (7) as a template; the PCR fragment was then introduced into pEGFP-N1 vector (Clontech).
Fam65b
(1) was PCR-amplified using T lymphocyte cDNA as a template and similarly 6 introduced into pEGFP-N1. V5-tagged Fam65b(2) truncated mutants were described (7).
ChIP assays
JTag cells infected with lentiviral vectors encoding GFP or FOXO1(3A)-GFP were used three days later for some ChIP experiments performed with the Chromatin Immunoprecipitation (ChIP) assay kit (Millipore) according to the manufacturer's instructions. Anti-GFP and control irrelevant rabbit IgG were purchased from Abcam. DNA was extracted using a phenol/chloroform method. PCR reactions were conducted using the ampliTaq Gold kit with Gene Amp using the following parameters: 30 cycles (94°C 30 s, 58°C 1 min, 72°C 1.5 min) and the indicated primers (Supplemental Fig. 2B , C). Migration of PCR products was then performed with 2.5% agarose gels.
Yeast two-hybrid screen
Yeast two-hybrid screening was performed by Hybrigenics (Paris, France) using full-length Fam65b(2) as bait to screen a random-primed human CD4 + CD8 + thymocytes cDNA library.
Cells
Human PBT were purified from the blood of healthy donors as described (8). Jurkat T Ag and 293T cells were cultivated in complete RPMI medium.
DNA and RNAi transfections
293T cells were transfected with Lipofectamine2000 (Invitrogen) according to the manufacturer's instructions. 2.10 6 Jurkat T antigen cells were nucleofected with 5 μg DNA using the Amaxa system (Lonza) (kit V, program X-001). 5.10 6 PBT per cuvette were nucleofected with 10 µg DNA of the indicated construct using Amaxa and the U14 program. 
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For RNAi experiments, 2.10 6 PBT per cuvette were nucleofected with 2 µl of a 100 µM solution of OTP smartpool RNAi (Dharmacon) directed against human Fam65b or nontargeting sequences as a control. Cells were rested for 10 min in RPMI at 37 °C and then supplemented with complete RPMI medium containing human AB serum and 5 U/ml IL-7.
Cells were then tested for functional experiments 3 days after nucleofection when the level of Fam65b knock-down was maximal.
Biochemistry
Protein expression levels of Fam65b were analysed by Western blot as described (8). Both 
RhoA activation assay
RhoA-GTP levels were measured using the G-LISA TM RhoA activation assay (Cytoskeleton).
PBT stimulated or not with CCL19 (200 ng/ml) for 30 sec were lysed for 30 min with occasional stirring in the following lysis buffer in the presence of complete protease inhibitors: 50 mM Hepes, 1% Triton-X100, 0.5% deoxycholate, 0.05% SDS, 500 mM NaCl, 
Nucleotide Exchange Kinetics Assay
Nucleotide exchange activity on 2 µM of RhoA was measured with or without 2 µM of Dbs using a RhoGEF exchange assay kit (Cytoskeleton, Inc.) according to the manufacturer instructions, except that 6His-RhoA was produced in our laboratory (9) . Fluorescence measurements were performed at 25 ˚C in a 384-well plate using a FlexStation 3 (Molecular Devices) with excitation and emission wavelengths of 360 and 440 nm, respectively. The Cruz) immunofluorescence was performed using a 10% trichloroacetic acid (TCA) fixation method together with a P-ERM (Cell Signaling Technology) staining to localize the uropod.
Unfortunately, Fam65b staining does not work with TCA fixation which precludes the possibility of performing a RhoA-Fam65b co-staining. DAPI or Hoechst stainings (blue) were used in some cases to stain the nucleus. Primary antibodies were revealed by biotin-, FITC-or
Texas Red-conjugated anti-rabbit, anti-mouse or anti-goat IgG antibodies (Jackson ImmunoResearch). Streptavidin-Alexa fluor TM 568 (Invitrogen) was used to reveal secondary biotinylated antibodies. T lymphocytes were then allowed to sediment, mounted on glass coverslips using FluorSave TM Reagent (Calbiochem) and imaged by confocal microscopy.
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Adhesion assays
For under-flow adhesion assays, CT or Fam65b KD T cells were resuspended at 10 6 /ml in standard adhesion buffer (PBS, 1 mM CaCl 2 , 1 mM MgCl 2 , 10 % FCS, pH 7.2). Cellular adhesive interactions were studied in underflow conditions with the BioFlux 200 system (Fluxion Biosciences). A 48-well plate microfluidics was first co-coated overnight at room temperature with human E-selectin (5 µg/ml; R&D system) and human ICAM-1 (5 µg/ml; R&D system) in PBS. Before use, microfluidic channels were washed with PBS, coated with 2 µM CCL19 in PBS for 3 h at room temperature and the assay was done at a wall shear stress force of 2 dyne/cm 2 . After extensive washing of channels with adhesion buffer, the behavior of interacting lymphocytes was recorded on digital drive with a fast CCD videocamera (25 frames/sec, capable of 1/2 subframe 20 msec recording) and analyzed subframe by subframe.
Single areas of 0.2 mm 2 were recorded for at least 120 sec. Interactions of 20 msec or longer were considered significant and scored. Lymphocytes that remained firmly adhesive for at least 1 sec were considered fully arrested. Cells arrested for at least 1 sec or 10 sec were scored.
In vivo lymphocyte arrest on blood vessels endothelial cells was studied by intravital microscopy as described (11) 
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Polarization T cell polarization assays and the analysis of the 4 categories of morphological changes elicited by CCL19 stimulation were performed as described (12) .
Migration
Nucleofected PBT were placed on the upper chamber of a 5-µm diameter transwell (Nunc).
Different concentrations of CCL19 were put in the lower chamber and the cells were allowed to migrate for 3 hours. Lymphocytes that had reached the lower chamber were then harvested, put in a FACScan tube together with an equal amount of flow check fluorspheres (Beckman Coulter). The number of migrating cells was analysed by flow cytometry relative to the number of beads.
Statistics
Means +/-SE are shown when indicated. Statistically significant differences between groups
were assessed with an unpaired Student's t test calculated with KaleidaGraph.
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Fam65b is induced by FOXO1
We initially identified fam65b as a major response gene of FOXO1 by microarray experiments in human T lymphocytes (3). Fam65b (Family with sequence similarity 65 member b) also called c6orf32, has two paralogs (Fam65a and Fam65c), all three molecules being well conserved from Zebra fish to humans (Supplemental Fig. 1A ), especially in their N-terminal regions. In humans, this gene is located on chromosome 6 and encodes two mRNA isoforms that give rise to two proteins (Supplemental Fig. 1B) . A UniGene search for the distribution of the transcripts indicated that fam65b mRNA levels are particularly high in blood cells and adult tissues of hematopoietic origin such as the secondary lymphoid organs (Supplemental Fig. 1C ).
As presented in supplemental figure 2, the fam65b gene encodes two mRNA isoforms.
To further characterize the regulation of Fam65b expression by FOXO1, we designed PCR primers amplifying specifically each isoform, and followed their expression in the Jurkat T cell line expressing a constitutively active nuclear form of FOXO1 (FOXO1(3A)). As shown in figure 1A as measured by qRT-PCR, Jurkat cells expressing FOXO1(3A) exhibited a 4.5 ± 0.1 and 6.5 ± 3 (mean ± S.E.M.) fold increase in Fam65b isoform 1 and isoform 2 transcript levels, respectively. The FOXO1(3A,H215R) mutant, which exhibits impaired DNA binding, induced only a marginal increase of 2 ± 0.1 for isoform 1 and 1.75 ± 0.35 for isoform 2 in transcript levels.
The two fam65b transcripts have their own promoters that have been identified using the Ensembl database (Supplemental Fig. 2A ). To determine whether FOXO1 directly controlled fam65b gene transcription, we searched for evolutionary conserved FOXO1-binding site in the two fam65b promoters with the Genomatix program. We found one The results show that the constitutively active form of FOXO1 induces Fam65b expression whereas the wild type form of FOXO1 fails to trigger this expression (Fig. 1D ). This is in accordance with its complete exclusion of the nucleus in this cellular model (Fig. 1E) 14 mutant (Fig. 1D ) despite its nuclear localization (Fig. 1E) . Moreover, we show that Fam65b induced by active FOXO1 exhibits a cytosolic distribution (Fig. 1E) .
Altogether, these results demonstrate that FOXO1 directly controls fam65b transcription and the expression of this protein in T lymphocytes.
Fam65b negatively regulates adhesion, polarization and migration upon chemokine stimulation
In unstimulated T cells, we and others have previously shown that FOXO1 controls the expression of CCR7 which binds the homeostatic chemokines CCL19 and CCL21 (3, 13).
CCR7 is crucial for lymph node homing (14) or during intra-nodal motility (15) (16) (17) ). Because we demonstrate here that FOXO1 also controls Fam65b expression in resting T lymphocytes, we next tested whether Fam65b plays a role in CCL19 responses.
Using a RNAi approach (Supplemental Fig. 3A) , we first tested whether Fam65b plays a role in T cell adhesion upon CCL19 stimulation. Adhesion under flow upon chemokine stimulation elicits a rapid inside-out mechanism of integrin activation that supports a quick cell arrest that might be followed by additional mechanisms to stabilize adhesion (18). Underflow adhesion assays were conducted for control (CT) and Fam65b knocked-down (KD) T lymphocytes visualised in microfluidic channels coated with CCL19, E-selectin and ICAM-1.
The behavior of CT and KD T cells is quantified in Fig. 2A . KD T cells have a lower tendency to exhibit rolling ( Fig. 2A, left) and reciprocally show an increased propensity to adhere briefly ( Fig. 2A, middle) or more stably ( Fig. 2A, right) . We next aimed at evaluating the adhesive role of Fam65b in the complexity of an in vivo situation under physiological shear stress forces. We used a validated xenobiotic setting that consists in imaging the microcirculation of human T cells in the Peyer's patches HEVs of anesthetized mice by intravital microscopy (11) . In these conditions, Fam65b depletion increases the percentage of 15 stably arrested T lymphocytes (Fig. 2B) . Therefore, Fam65b negatively regulates T lymphocyte adhesion, both in vitro and in vivo.
We then analysed the capacity of Fam65b KD cells to polarize morphologically upon CCL19 stimulation as described (12) . Interestingly, even without any chemokine stimulation, Fam65b KD cells tend to spontaneously polarize slightly more than control cells (Fig. 2C) .
After CCL19 stimulation, twice as many KD cells progressed toward the fully polarized stage compared to control cells (Fig. 2C) .
As polarity establishment is considered to be a prerequisite for optimal migration (19, 20), we next aimed at testing a role for Fam65b in T cell migration. We first observed that in absence of chemokine stimulation, KD cells are more prone to migrate spontaneously (Fig.   2D ). This phenomenon was more amplified at sub-optimal CCL19 concentration, as the sole
Fam65b depletion was able to turn immobile cells into lymphocytes efficiently migrating 4
times above the baseline level (Fig. 2D, middle) , most likely due to the higher fraction of polarized cells.
Altogether, these results show that Fam65b negatively regulates the threshold for T cell adhesion, polarisation and migration.
Fam65b is a new partner of RhoA
In our initial attempt to delineate the signaling pathways regulated by Fam65b, several independent observations pointed toward the RhoA GTPase. (i) A remarkable aspect is that the T cell functions reported above, in which Fam65b has an inhibitory role, have been reported to depend on RhoA activity, whereas actin polymerization in primary T lymphocytes is controlled neither by RhoA nor by Fam65b (Supplemental Fig. 3B ) (21-25).
(ii) An in silico approach using Panther classification system for phylogenetically related proteins identified Fam65b as a molecule related to the RhoA partner PKN (26, 27) (PTHR15829).
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(iii) A yeast two-hybrid screen set up for identifying Fam65b partners identified the small GTPase RhoA as a possible candidate for Fam65b binding.
In order to confirm this interaction, we realized a series of pull-down assays. As shown in figure 3A and B, both Fam65b isoforms strongly interact with RhoA in an inactive GDPbound form as well as an active GTP-bound form. Titering down the amount of RhoA-GDP or RhoA-GTP in this assay still maintained similar binding to Fam65b (Fig. 3C) , irrespective of the type of nucleotide loaded. Association of Fam65b with wild-type RhoA or the constitutively active mutant RhoAL63 was also detected purely in vitro with recombinant proteins, demonstrating a direct association between Fam65b and RhoA (Fig. 3D ).
We next attempted to identify the Fam65b region responsible for RhoA binding. A series of truncated Fam65b mutants was tested in a pull-down assay. N-terminal deletion of the first 54 amino acids maintained the ability of this mutant to bind RhoA (Fig. 3E ).
However, removal from amino acid 113 and beyond completely abrogated RhoA interaction.
Conversely, deletion of the last 101 amino acids did not affect binding to RhoA. We conclude that Fam65b binds RhoA through the 54-113 region of Fam65b.
In addition, this interaction between RhoA and endogenous Fam65b in the lysates of primary human T cells was detected (Fig. 3F) . Importantly, whereas a strong association was observed in un-stimulated T lymphocytes, it was transiently decreased upon CCL19
stimulation. This result indicates that CCL19 signaling frees RhoA from Fam65b binding.
Fam65b inhibition of migration depends on RhoA binding
We next aimed at determining whether the Fam65b-RhoA interaction could account for the effect of Fam65b on T cell migration.
We first checked whether RhoA controls T cell migration as described for many other cell types (5). This was verified in our system for T cell migration elicited by CCL19
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17 signaling using a dominant negative mutant of RhoA. The inhibition of RhoA activity elicited a strong inhibition of T cell migration (Fig. 4A) . Overexpression of full-length Fam65b also inhibited T cell migration whereas the Δ113 mutant, that does not bind RhoA, did not (Fig.   4B ). This result confirms the inhibitory effect of Fam65b on chemokine-induced migration, and unveils the requirement for the RhoA binding region of the protein for this inhibition.
Fam65b inhibits RhoA activity
The functional effects of Fam65b on migration could thus arise from an inhibition of the activity of its partner RhoA. To further test this hypothesis, we directly measured the content of active GTP-bound RhoA in Fam65b-KD or control cells. The results show that resting KD cells had a higher content in RhoA-GTP that did not increase substantially after chemokine stimulation contrary to control T cells (Fig. 5A) . Thus, Fam65b acts as a factor that tonically inhibits the RhoA pathway by decreasing the T cell RhoA-GTP content.
In order to delineate the molecular mechanism by which Fam65b inhibits RhoA activity, we also performed an in vitro nucleotide exchange assay to measure the kinetics of RhoA GTP loading by the Guanine nucleotide Exchange Factor (GEF) domain of the RhoGEF Dbs in the presence of Fam65b. In a solution containing fluorescent GTP, we could observe a slow and passive loading of GTP on RhoA that was largely independent of the presence of Fam65b (Fig. 5B, left) . Addition of recombinant Dbs accelerated GTP loading as expected. However, the presence of Fam65b slowed down the exchange rate of Dbs on RhoA, as shown by a 5-times reduction in the k obs value (Fig. 5B, right) .
Therefore, we conclude that Fam65b down-modulates the exchange reaction that GEFs perform on RhoA and consequently dampens levels of active RhoA in T cells. We show that Fam65b markedly affects adhesion, polarization and migration upon chemokine exposure although it does so without exhibiting obvious changes in its subcellular localization (Supplemental Fig. 4A ). This is in agreement with the fact that Fam65b can interact with RhoA independently of the type of nucleotide it bears and that the total pool of RhoA is distributed on both sides of a polarised T cell (Supplemental Fig. 4B ) (10) . We report here that Fam65b exerts a tonic inhibition on RhoA activity. Together with other necessary signaling pathways triggered upon chemokine stimulation, the depletion in Fam65b is thus likely to account for the advantage exhibited by the KD cells to polarize and migrate. We show here that Fam65b inhibits the exchange reaction performed by GEFs on RhoA. It would be interesting to determine whether these three non canonical RhoA partners, i.e. F11L, Memo and Fam65b, share a similar regulatory mechanism on RhoA.
Fam65b has previously been shown to be up-regulated during placenta and muscle cell differentiation and to induce membrane protrusions necessary for cell-cell fusion (7, 30, 31) .
In fact, it is the 54-113 portion of the protein that is required for this morphological effect in myoblasts (7) . Interestingly, we show that this particularly well conserved region related to PKN and predicted to display a coiled-coil structure is necessary to bind RhoA, suggesting that the effect of Fam65b on myoblast fusion may depend on its ability to interact with RhoA and to inhibit its activity. Consistent with this model, others have shown that a decrease in RhoA-GTP content was indispensable to allow myoblast fusion (32). Therefore, we consider most likely that Fam65b behaves as an inducible repressor of RhoA activity to allow cell-cell In conclusion, we have identified here a new RhoA down-modulator whose expression is tightly controlled by FOXO1. Although our data have been obtained in T lymphocytes, the mechanisms uncovered in these cells may be of much wider significance in other cell types for contributing to other cell-specific functions. We have shown that Fam65b acts as a brake for T cell migration, and therefore represents a new target by which FOXO1 can regulate motile processes. 
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